By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted May 26, 2022APYX MEDICAL CORPORATION RECEIVES FDA 510(K) CLEARANCE FOR THE USE OF RENUVION COSMETIC TECHNOLOGY IN DERMAL RESURFACING PROCEDURES READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted May 25, 2022APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN JUNE READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted May 12, 2022APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND UPDATES FULL YEAR 2022 FINANCIAL OUTLOOK READ MORE